Priam Villalonga

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Escherichia Coli

Tyrosine Kinase

Top Venues

Cellular oncology (Dordrecht)

This page only lists publications with an associated author ORCID identifier.

Publications

Beatriz Almarán, Guillem Ramis, Silvia Fernández de Mattos, Priam Villalonga
Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling. Cells 11 (23) (2022)
Beatriz Almarán, Guillem Ramis, Silvia Fernández de Mattos, Priam Villalonga
Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling. Cells 11 (23) (2022)
Beatriz Almarán, Guillem Ramis, Silvia Fernández de Mattos, Priam Villalonga
Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling. Cells 11 (23) (2022)
Beatriz Almarán, Guillem Ramis, Silvia Fernández de Mattos, Priam Villalonga
Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling. Cells 11 (23) (2022)
Guillem Ramis, Ruth Villalonga-Planells, Margalida Serra-Sitjar, Marta Brell, Silvia Fernández de Mattos, Priam Villalonga
The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells. Cellular oncology (Dordrecht) 42 (4) (2019)